This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
AHCO vs. SYK: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AHCO vs. SYK: Which Stock Is the Better Value Option?
AdaptHealth (AHCO) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
AdaptHealth (AHCO) has been struggling lately, but the selling pressure may be coming to an end soon
Company News for Mar 5, 2021
by Zacks Equity Research
Companies in The news Are: KR,MEI,AHCO,PRPL
AdaptHealth Corp. (AHCO) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
AdaptHealth Corp. (AHCO) delivered earnings and revenue surprises of 92.31% and 6.85%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Boston Scientific (BSX) Enhances Core Business With Buyout
by Zacks Equity Research
Boston Scientific's (BSX) acquisition of Preventice solutions enables the former to expand rhythm management diagnostics portfolio and abilities.
Integra (IART) Acquires Acell, Focuses on Regenerative Space
by Zacks Equity Research
The acquisition is expected to remain accretive to Integra's (IART) revenue growth and adjusted gross margins.
Globus Medical (GMED) US Spine Grows, Pricing Pressure Stays
by Zacks Equity Research
Globus Medical's (GMED) recent product launches are seeing tremendous uptake.
Insulet (PODD) Omnipod DASH Reaches Canada, Global Hold Widens
by Zacks Equity Research
Insulet's (PODD) Omnipod DASH system provides 72 hours of continuous insulin therapy, simplifying lives with no more daily injection.
PerkinElmer (PKI) Receives FDA EUA for Asymptomatic Testing
by Zacks Equity Research
PerkinElmer's (PKI) RT-PCR assay to test individuals without COVID-19 symptoms acts as prime factor in controlling the spread.
Rockwell Medical (RMTI) Looks Good: Stock Adds 5.9% in Session
by Zacks Equity Research
Rockwell Medical (RMTI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Neogen (NEOG) Launches Dairy Toxin Detection Test Reveal Q+
by Zacks Equity Research
Neogen's (NEOG) new test can detect cancer causing aflatoxin M1 in milk within a range of 150-600 parts per trillion (ppt).
Baxter (BAX) Inks Sterile Manufacturing Agreement With Novavax
by Zacks Equity Research
Baxter's (BAX) BioPharma Solutions business inks deal to advance commercial-scale production and increase access for the COVID-19 vaccine in the U.K. and European markets.
Company News for Dec 2, 2020
by Zacks Equity Research
Companies In The News Are: TSLA, KSS, AHCO, XOM
The Zacks Analyst Blog Highlights: PulteGroup, American Water Works, Kinross, AdaptHealth and Procter & Gamble
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PulteGroup, American Water Works, Kinross, AdaptHealth and Procter & Gamble
5 Stocks to Add as Fed Keeps Rates Unchanged
by Tirthankar Chakraborty
We have selected five stocks that are positioned to gain from the Fed's holding of interest rates at an all-time low.
AdaptHealth's Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in AdaptHealth.
AdaptHealth (AHCO) Catches Eye: Stock Jumps 6.5%
by Zacks Equity Research
AdaptHealth (AHCO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Is DFB Healthcare Acquisitions Corp. (AHCO) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
DFB Healthcare Acquisitions Corp. (AHCO) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
DFB Healthcare Acquisitions Corp. (AHCO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for April 28th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Are Investors Undervaluing DFB Healthcare Acquisitions Corp. (AHCO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: AdaptHealth, FGL and Kinross Gold
by Zacks Equity Research
Zacks.com featured highlights include: AdaptHealth, FGL and Kinross Gold
Pick These 3 Breakout Stocks for Explosive Returns
by Nitish Marwah
Picking breakout stocks is one of the most favored methods for people utilizing an active investing approach as this strategy offers scope for superlative returns.
Can DFB Healthcare Acquisitions Corp. (AHCO) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
DFB Healthcare Acquisitions Corp. (AHCO) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
EYE vs. AHCO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
EYE vs. AHCO: Which Stock Is the Better Value Option?